Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial (September 19, 2014)

DNAtrix, Inc., experts in oncolytic virus development, today announced that the first patient was treated with the company’s lead product, DNX-2401, a replication competent adenovirus plus gamma... Continue Reading

Monday-9/22: Ovarian Cancer Talk: Participate in a Live Video Chat With the Experts from Roswell Park Cancer Institute (September 18, 2014)

Straight from Roswell Park Cancer Institute in Buffalo, N.Y., to your computer or mobile device, four leading experts in ovarian cancer will broadcast a live, interactive video chat from 6 to 7 p.m. on... Continue Reading

Bayer and Orion Initiate Phase III Trial of Novel Prostate Cancer Agent ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (September 18, 2014)

Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational novel oral androgen receptor... Continue Reading

Breast Conservation Therapy May Be Better than a Mastectomy (September 17, 2014)

Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Early-stage breast cancer refers to cancer that has not spread from its site of origin. Patients with early-stage... Continue Reading

Vaccine Derived from HER2 Protein May Help Prevent Breast Cancer Recurrence (September 16, 2014)

A new breast cancer vaccine that is derived from the HER2 protein may help prevent recurrence in patients with HER2-positive disease and appears safe. Phase II study results of the vaccine were released... Continue Reading

FDA Approves Use of Xtandi for Chemotherapy Naïve Men With Advanced Prostate Cancer (September 15, 2014)

The FDA approved the use of Xtandi® (enzalutamide) in men who have not yet received chemotherapy, significantly expanding the potential patient population eligible to be treated with the oral medicine. ... Continue Reading

Wider Genetic Screening For Breast Cancer? (September 12, 2014)

Geneticist Mary-Claire King of the University of Washington, responsible for the identification of the first breast cancer genes BRCA1 and BRCA2, is recommending that all women get tested for genetic mutations... Continue Reading

New Survey Reveals that Prostate Cancer Impacts Sex Lives More than Any Other Aspect of Patients’ Lives (September 11, 2014)

Washington, DC (September 8, 2014) – A recent survey conducted by ZERO – The End of Prostate Cancer and Ferring Pharmaceuticals Inc. aimed to uncover the impact of prostate cancer on patients, their... Continue Reading

National Thyroid Cancer Awareness Month on CancerConnect (September 10, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of educational programs for national thyroid cancer awareness month. As the month of September brings thyroid cancer... Continue Reading

Promising Activity of Imbruvica Plus Rituxan in High-Risk CLL (September 10, 2014)

Researchers from MD Anderson Cancer Center recently reported in the journal The Lancet Oncology that the combination of Imbruvica® (ibrutinib) and Rituxan® (rituximab) showed promising activity in the... Continue Reading

National Gynecologic Cancer Awareness Month on CancerConnect (September 9, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational programs for national gynecologic cancer awareness month.... Continue Reading

New Guidelines on Treatment of HER2-Negative Breast Cancer Aim to Improve Patient Outcomes (September 9, 2014)

The American Society of Clinical Oncology (ASCO) recently released updated guidelines for the treatment of advanced HER2-negative breast cancer. The Journal of Clinical Oncology will publish the new guidelines,... Continue Reading

Molecular Subtyping Can Improve Breast Cancer Treatment (September 8, 2014)

IRVINE, CA and AMSTERDAM – In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information... Continue Reading

September Is National Blood Cancer Awareness Month (September 5, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of blood cancer educational programs for national blood cancer awareness month. As the month of September brings blood... Continue Reading

Pembrolizumab Gets FDA Approval in Advanced Melanoma (September 5, 2014)

The U.S. Food & Drug Administration (FDA) has granted approval to Merck’s new immunotherapy drug, Keytruda (pembrolizumab), for treating metastatic melanoma.   It is the first anti-PD-1 drug, aimed... Continue Reading

Adding Revlimid to R-CHOP May Improve Outomes of Selected Patients with NHL (September 4, 2014)

The results of a recently completed study reported in the Journal of Clinical Oncology indicate that the addition of Revlimid® (lenalidomide) to R-CHOP the standard treatment for non hodgkin lymphoma... Continue Reading

September Brings Awareness to Prostate Cancer (September 4, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of prostate cancer programs for national prostate cancer awareness month.  Prostate cancer is the most frequently diagnosed... Continue Reading

Cabozantinib Development in Prostate Cancer Halted (September 3, 2014)

Development of the investigational drug cabozantinib that initially showed promise in the treatment of metastatic, hormone-refractory prostate cancer has been halted due to discouraging results in a pivotal... Continue Reading

Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells Reported to be Effective in Aggressive Non-Hodgkin’s Lymphoma at the National Cancer Institute (NCI) (September 3, 2014)

SANTA MONICA, Calif., Aug. 25, 2014 (GLOBE NEWSWIRE) — Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™)... Continue Reading

National Ovarian Cancer Awareness Month on CancerConnect (September 2, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of ovarian cancer educational programs for national ovarian cancer awareness month. As the month of September brings... Continue Reading

Depression in Cancer Patients: What We Are Missing and What Can Be Done (September 2, 2014)

Major depression is an important complication of cancer that can result in additional impairment of quality of life.  A series of three articles published in the Lancet presented new research on depression... Continue Reading

Interim Results of X-396 in ALK positive Non-Small Cell Lung Cancer Appear Promising (August 29, 2014)

Preliminary results from a small phase 1 study of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor showed that X-396 is well tolerated and has antitumor activity in patients with ALK positive... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence... Continue Reading

Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer (August 27, 2014)

Advaxis, Inc.a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Merck to evaluate the safety and efficacy of ADXS-PSA... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS